Name | osteopontin |
---|---|
Synonyms | BNSP; Spp1; BSPI; Bone sialoprotein; Bone sialoprotein 1; ETA 1; ETA1; Early T lymphocyte activation 1… |
Name | phosphorus |
---|---|
CAS | phosphorus |
PubMed | Abstract | RScore(About this table) | |
---|---|---|---|
19322138 | El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, Ingalls CM, Liao HW, Giachelli CM: medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int. 2009 Jun;75(12):1297-307. Epub 2009 Mar 25. |
feeding induces arterial 8(0,0,1,3) | Details |
19789408 | Ishizeki K, Kagiya T, Fujiwara N, Otsu K, Harada H: Expression of osteogenic proteins during the intrasplenic transplantation of Meckel's chondrocytes: A histochemical and immunohistochemical study. Arch Histol Cytol. 2009 Mar;72(1):1-12. Type I, II, and X collagens, and the bone-marker proteins osteocalcin, osteopontin, osteonectin, and bone morphogenetic protein-2 (BMP-2) were immunolocalized in the matrix formed by the transplanted chondrocytes. |
2(0,0,0,2) | Details |
20004751 | Sethuraman S, Nair LS, El-Amin S, Nguyen MT, Singh A, Krogman N, Greish YE, Allcock HR, Brown PW, Laurencin CT: Mechanical properties and osteocompatibility of novel biodegradable Moreover, cells on the surface of the polymers expressed type I collagen, alkaline phosphatase, osteocalcin, osteopontin, and bone sialoprotein, which are characteristic genes for osteoblast maturation, differentiation, and mineralization. Biodegradable polyphosphazenes are high-molecular-weight polymers with alternating and phosphorus atoms in the backbone. |
based polyphosphazenes: Side group effects. Acta Biomater. 2009 Dec 24.1(0,0,0,1) | Details |
19621927 | Costa-Pinto AR, Correlo VM, Sol PC, Bhattacharya M, Charbord P, Delorme B, Reis RL, Neves NM: Osteogenic differentiation of human bone marrow mesenchymal stem cells seeded on melt based scaffolds for bone tissue engineering applications. Biomacromolecules. 2009 Aug 10;10(8):2067-73. The presence of mineralized extracellular matrix (ECM) was successfully demonstrated by peaks corresponding to and phosphorus elements detected in the EDS analysis. Moreover, by reverse transcriptase (RT)-PCR analysis, it was observed the expression of osteogenic gene markers, namely, Runt related transcription factor 2 (Runx2), type 1 collagen, bone sialoprotein (BSP), and osteocalcin. |
1(0,0,0,1) | Details |
19601862 | Brancaccio D, Bellasi A, Cozzolino M, Galassi A, Gallieni M: Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification. Curr Vasc Pharmacol. 2009 Jul;7(3):374-80. Indeed, the co-localization of bone markers such as Osteopontin, Alkaline Phosphatase and Osteocalcin along with osteoblast-like cells in the contest of the arterial wall of uremic patients, indicate that VC is an active biological process with peculiar analogies with bone mineralization. |
1(0,0,0,1) | Details |
19345526 | Torres PA: [Origin of the mediacalcosis in kidney failure] . J Mal Vasc. 2009 May;34(3):204-10. Epub 2009 Apr 3. It is now possible to identify factors clearly favoring the formation of VC: TNF-alpha (which stimulates cell necrosis/apoptosis), CRP, oxidized lipids, AGEs, leptin, inorganic high -phosphorus product (CaxPO (4)), 1,25-OH (2) D (3) and (3), PTHrP (via an intracrine pathway), cyclic AMP, TGF-beta, bone morphogenic protein 2 (BMP2) and factors protective against the formation of VC: HDL, inorganic albumin, ahsg/fetuin A, osteopontin (OPN), osteoprotegerin (OPG), osteonectin (ON), bone morphogenic protein 7 (BMP7), klotho, PTHrP (via a paracrine pathway), matrix gla protein (MGP), PTH (via Msx2) and |
31(0,1,1,1) | Details |
19546357 | Zhou YB, Jin SJ, Cai Y, Teng X, Chen L, Tang CS, Qi YF: Lanthanum inhibits vascular calcification induced by plus in rats. Exp Biol Med. 2009 Aug;234(8):908-17. Epub 2009 Jun 22. As compared with control rats, rats with calcification showed widespread calcified nodules and irregular elastic fibers in calcified aorta on von Kossa staining and increased aortic and phosphorus contents, alkaline phosphatase (ALP) activity and bone-related protein expressions for osteopontin (OPN) and type III dependent cotransporter Pit-1 (Pit-1). |
6(0,0,1,1) | Details |
19913918 | Das S, Sinha S, Britto R, Somasundaram K, Samuelson AG: Cytotoxicity of half sandwich ruthenium (II) complexes with strong bond acceptor ligands and their mechanism of action. J Inorg Biochem. 2010 Feb;104(2):93-104. Epub 2009 Oct 8. In cationic complexes, X, Y is either a eta (2) phosphorus ligand such as 1,1-bis (diphenylphosphino) (DPPM) and 1,2-bis (diphenylphosphino) ethane (DPPE) or partially oxidized ligands such as 1,2-bis (diphenylphosphino) monooxide (DPPMO) and 1,2-bis (diphenylphosphino) ethane monooxide (DPPEO) which are strong bond acceptors. Complexes with DPPM and DPPMO ligands ([(eta (6)- Ru (eta (2)-DPPM) Cl] PF (6) (R2), [(eta (6)- Ru (eta (2)-DPPMO) Cl] PF (6) (R3), [(eta (6)- Ru (eta (1)-DPPM) Cl (2)] (R5) and [(eta (6)- Ru (eta (1)-DPPMO) Cl (2)] (R6) show good cytotoxicity. |
1(0,0,0,1) | Details |